{
    "2019-07-29": [
        [
            {
                "time": "2019-07-26",
                "original_text": "Edited Transcript of ABBV earnings conference call or presentation 26-Jul-19 1:00pm GMT",
                "features": {
                    "keywords": [
                        "ABBV",
                        "earnings",
                        "conference",
                        "call",
                        "presentation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "Noteworthy Monday Option Activity: SYNA, ABBV, VGR",
                "features": {
                    "keywords": [
                        "SYNA",
                        "ABBV",
                        "VGR",
                        "option",
                        "activity"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals",
                        "utilities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-26",
                "original_text": "Pfizer to Combine Off-Patent Drug Business With Mylan",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "off-patent",
                        "drug",
                        "business",
                        "Mylan",
                        "combine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}